Ariel Katz, H1

H1 has raised over $200m to build out a very comprehensive data set of physicians internationally. Those products were primarily aimed at pharma. Now they are moving into the world of managing physician data for plans and providers, primarily via the 2025 acquisitions of Ribbon Health and Veda Health. I spoke with CEO Ariel Katz,…

Read More

Frozen Does Not Mean Stable: Rethinking Cryopreservation in Cell and Gene Therapy Manufacturing

As cell-based therapies grow more complex and manufacturing networks expand, resilience can’t be an afterthought, and cryopreservation can no longer just be a step that gets validated during development and left alone. It needs to play an ongoing role in product consistency, potency, and reliability. The post Frozen Does Not Mean Stable: Rethinking Cryopreservation in…

Read More

The Aging Crisis Is Here, and Technology Is No Longer Optional

We need to pivot from a deficiency to an abundance model – from over-focusing on what an individual cannot do, to making the most of the physical and mental resources at hand to maximize independence, dignity, and quality of life. This includes rethinking physical environments and thoughtfully embedding technology to support capability rather than limitation…

Read More